+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Clinical characteristics of depressive symptoms in children and adolescents with major depressive disorder



Clinical characteristics of depressive symptoms in children and adolescents with major depressive disorder



Journal of Clinical Psychiatry 65(12): 1654-9; Quiz 1760-1



Very few studies have compared the symptoms of major depressive disorder (MDD) and rates of comorbid psychiatric disorders between depressed children and adolescents. The aim of this study was to reproduce and extend these findings. The Kiddie Schedule for Affective Disorders and Schizophrenia, present version (KSADS-P) was administered to parents (about their children) and in face-to-face interviews with 916 subjects aged 5.6 to 17.9 years with MDD (DSM criteria) (715 adolescents and 201 children; 348 male and 568 female). The subjects were consecutive referrals to an outpatient mood and anxiety disorders clinic. Depressed adolescents had significantly more hopelessness/helplessness, lack of energy/tiredness, hypersomnia, weight loss, and suicidality compared with children (p values < or = .001). In comparison with children, adolescents had significantly more substance abuse and less comorbid separation anxiety disorder and attention-deficit/hyperactivity disorder (p values < or = .001). Depressed female adolescents had significantly more suicidality than depressed male adolescents (p < or = .001). There were no other sex differences between males and females. The symptoms of depressed adolescents grouped into 3 factors (endogenous, negative cognitions/suicidality, and appetite/weight), whereas the symptoms in children grouped into 2 factors (endogenous/negative cognitions/suicidality and appetite/weight). These results provide further evidence for the continuity of MDD from childhood to adolescence.

Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 048542025

Download citation: RISBibTeXText

PMID: 15641870


Related references

Fluoxetine decreased depressive symptoms in children and adolescents with non-psychotic major depressive disorder. Evidence-Based Mental Health 1(2): 49-49, 1998

Comparison of demographic and clinical characteristics between children and adolescents with major depressive disorder. Revista Brasileira de Psiquiatria 30(2): 124-131, 2008

Time Spent with Parents Predicts Change in Depressive Symptoms in Adolescents with Major Depressive Disorder. Journal of Abnormal Child Psychology 2019, 2019

Escalation to Major Depressive Disorder among adolescents with subthreshold depressive symptoms: evidence of distinct subgroups at risk. Journal of Affective Disorders 158: 133-138, 2015

Sertraline improves symptoms in children and adolescents with major depressive disorder. Evidence-Based Mental Health 7(1): 10, 2004

The role and clinical significance of subsyndromal depressive symptoms (SSD) in unipolar major depressive disorder. Journal of Affective Disorders 45(1-2): 5-18, 1997

Clinical Significance of the Number of Depressive Symptoms in Major Depressive Disorder: Results from the CRESCEND Study. Journal of Korean Medical Science 31(4): 617-622, 2016

Efficacy of anti-inflammatory treatment on major depressive disorder or depressive symptoms: Meta-analysis of clinical trials. Acta Psychiatrica Scandinavica 2019, 2019

Observational measurement of symptoms responsive to treatment of major depressive disorder in children and adolescents. Journal of Nervous and Mental Disease 180(10): 639-643, 1992

Use of antidepressants for major depressive disorder in children and adolescents: clinical considerations. International Journal of Adolescent Medicine and Health 25(3): 213-219, 2014

Add-on high frequency deep transcranial magnetic stimulation (dTMS) to bilateral prefrontal cortex in depressive episodes of patients with major depressive disorder, bipolar disorder I, and major depressive with alcohol use disorders. Neuroscience Letters 671: 128-132, 2018

Major depressive disorder in children and adolescents: clinical trial design and antidepressant efficacy. Journal of Clinical Psychiatry 66 Suppl 7: 14-20, 2005

The Impact of a Single Nucleotide Polymorphism in SIGMAR1 on Depressive Symptoms in Major Depressive Disorder and Bipolar Disorder. Advances in Therapy 34(3): 713-724, 2017

Negative mood, depressive symptoms, and major depression after smoking cessation treatment in smokers with a history of major depressive disorder. Journal of Abnormal Psychology 111(4): 670-675, 2002

Persistent depressive disorder has long-term negative impacts on depression, anxiety, and somatic symptoms at 10-year follow-up among patients with major depressive disorder. Journal of Affective Disorders 243: 255-261, 2018